Can existing unrelated vaccines boost a COVID-19 vaccine prime?

by Nathaniel Hupert, Daniela Marín-Hernández, Douglas F. Nixon
Published 2021-02-01

Extreme immunotherapy: emergency immunology to defeat pandemics

by Douglas F. Nixon, Daniela Marín-Hernández, Nathaniel Hupert
Published 2021-09-01

Heterologous vaccine interventions: boosting immunity against future pandemics

by Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert
Published 2021-05-01

Allatostatin C modulates nociception and immunity in Drosophila

by Nathaniel D. Bachtel, Gary A. Hovsepian, Douglas F. Nixon, Ioannis Eleftherianos
Published 2018-05-01

TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

by Robert L. Furler, Douglas F. Nixon, Christine A. Brantner, Anastas Popratiloff, Christel H. Uittenbogaart
Published 2018-06-01

Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort

by Timothy R Powell, Matthew Hotopf, Stephani L Hatch, Gerome Breen, Rodrigo R R Duarte, Douglas F Nixon
Published 2021-01-01

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target

by Gislaine Curty, Jez L. Marston, Miguel de Mulder Rougvie, Fabio E. Leal, Douglas F. Nixon, Marcelo A. Soares
Published 2020-07-01

Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.

by R Brad Jones, Keith E Garrison, Jessica C Wong, Erick H Duan, Douglas F Nixon, Mario A Ostrowski
Published 2008-01-01

Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.

by Emily M Eriksson, Chris E Keh, Steven G Deeks, Jeffrey N Martin, Frederick M Hecht, Douglas F Nixon
Published 2012-01-01

Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival

by Allison R. Kolbe, Matthew L. Bendall, Alexander T. Pearson, Doru Paul, Douglas F. Nixon, Marcos Pérez-Losada, Keith A. Crandall
Published 2020-08-01

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

by Dominic Paquin-Proulx, Benjamin C Greenspun, Emanuela A S Costa, Aluisio C Segurado, Esper G Kallas, Douglas F Nixon, Fabio E Leal
Published 2017-01-01

Enriched environment and stress exposure influence splenic B lymphocyte composition.

by Blake T Gurfein, Burcu Hasdemir, Jeffrey M Milush, Chadi Touma, Rupert Palme, Douglas F Nixon, Nicholas Darcel, Frederick M Hecht, Aditi Bhargava
Published 2017-01-01

Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

by Karina I Carvalho, Karina M Melo, Fernanda R Bruno, Jennifer E Snyder-Cappione, Douglas F Nixon, Beatriz T Costa-Carvalho, Esper G Kallas
Published 2010-09-01

A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.

by Jennifer E Snyder-Cappione, Camilla Tincati, Ijeoma G Eccles-James, Amedeo J Cappione, Lishomwa C Ndhlovu, Laura L Koth, Douglas F Nixon
Published 2010-11-01

Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.

by Brinda Emu, Walter J Moretto, Rebecca Hoh, Melissa Krone, Jeffrey N Martin, Douglas F Nixon, Steven G Deeks, Joseph M McCune
Published 2014-01-01

A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

by Karina M Melo, Karina I Carvalho, Fernanda R Bruno, Lishomwa C Ndhlovu, Wassim M Ballan, Douglas F Nixon, Esper G Kallas, Beatriz T Costa-Carvalho
Published 2009-07-01

Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.

by Aashish R Jha, Douglas F Nixon, Michael G Rosenberg, Jeffrey N Martin, Steven G Deeks, Richard R Hudson, Keith E Garrison, Satish K Pillai
Published 2011-01-01

The behavioral, cellular and immune mediators of HIV-1 acquisition: New insights from population genetics

by Timothy R. Powell, Rodrigo R. R. Duarte, Matthew Hotopf, Stephani L. Hatch, Miguel de Mulder Rougvie, Gerome D. Breen, Cathryn M. Lewis, Douglas F. Nixon
Published 2020-02-01

Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.

by Emily M Eriksson, Teri Liegler, Chris E Keh, Annika C Karlsson, Sara J Holditch, Christopher D Pilcher, Lisa Loeb, Douglas F Nixon, Frederick M Hecht
Published 2014-01-01

Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.

by Chris E Keh, Aashish R Jha, Bridget Nzarubara, David E Lanar, Sheetij Dutta, Michael Theisen, Philip J Rosenthal, Grant Dorsey, Douglas F Nixon, Bryan Greenhouse
Published 2012-01-01